Lisa F.P. Ng

Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)

1 Fusionopolis Way

#16-16 Connexis

Singapore, 138632

Singapore

SCHOLARLY PAPERS

5

DOWNLOADS

491

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

COVID-19 and Beyond: A Call for Action and Audacious Solidarity to All the Citizens and Nations, It Is Humanity’s Fight

Number of pages: 13 Posted: 25 Jun 2020
EISBM, LCSB, ELIXIR, Oswaldo Cruz Foundation, EISBM, IGIB, Global Virus Network, University of South Florida, Policlinico Gemelli, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Pitié-Salpêtrière Hospital, Smorodintsev Research Institute of Influenza, CERN, MILS, University of Manchester - School of Computer Science, KAUST, Swedish Medical Group, Providence St Joseph Health, Université Libre de Bruxelles (ULB), Data Science Institute, Imperial College London, Institute for Systems Biology, Institute for Systems Biology, Auckland Bioengineering Institute, The University of Auckland, Fudan University - Collaborative Innovation Center for Genetics and Development, OIST, McGill University - Centre for Genomics and Policy, Weizmann Institute of Science - Department of Molecular Genetics, IBBL, McGill Genome Centre, Lyon-Sud Hospital, Center for Research and Interdisciplinarity (CRI), Université de Paris, Faculté de Médecine, Université de Nantes, Estonian Genome Centre, Institute of Genomics, University of Tartu, APC, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Service de Pulmonologie, Centre Hospitalier Vaudois, University of Oxford, Paris-Meudon Observatory, Vienna Science and Technology Fund, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, University of Ibadan, University of Cambridge, Imperial College London, Izmir Biomedicine and Genome Center, Dokuz Eylul University, Patient Access Partnership, National Institute of Communicable Diseases, University Grenoble Alpes - Centre Hospitalier Universitaire de Grenoble (CHU Grenoble Alpes), Vanda Pharmaceuticals, Italian Association for Systems Medicine and Healthcare, San Filippo Neri Hospital, Technische Universität München (TUM) - Institute of Virology, Thorax Clinical Institute, Hospital Clinic, Faculty of Medicine, University of Ljubljana, Center for Research and Interdisciplinarity (CRI), Université de Paris, Institut Hospital de Mar de Investigaciones Mèdiques (IMIM), Universitat Pompeu Fabra, Policlinico Gemelli, Weizmann Institute of Science - Department of Computer Science and Applied Mathematics, Library of Alexandria, University of Illinois College of Medicine, Amsterdam University Medical Centre, University of Amsterdam, Department of Medical Genome Sciences, University of Tokyo, Research Center for Molecular Medicine, Medical University of Vienna, Asthma-UK, Karolinska Institutet - Computational Medicine Unit, Royal Institute of Technology (KTH) - Science for Life Laboratory, Policlinico Gemelli, Barcelona Supercomputing Center, Catholic University of the Sacred Heart, Rome - Fondazione Policlinico Gemelli, University of Paris-Saclay - Molecular Genetics of RNA Viruses, International Clinical Research Center, St. Anne's University Hospital, University Rostock, Institute of Computer Science, Department of Systems Biology and Bioinformatics and University Hospital Maastricht
Downloads 418 (85,239)

Abstract:

Loading...

COVID-19, SARS-CoV-2, coronavirus, pandemic, immune system, inflammation, systems medicine, global healthcare, call for action, international coalition

2.

Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study

Number of pages: 33 Posted: 05 Jan 2021
National Centre for Infectious Diseases, Singapore, National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Government of the Republic of Singapore - Communicable Diseases Division, Ministry of Health, Singapore, National Centre for Infectious Diseases, Singapore, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Singapore General Hospital - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Khoo Teck Puat Hospital, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, Duke-NUS Medical School, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Duke NUS Medical School, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, National Centre for Infectious Diseases, Singapore and Ministry of Health, Singapore
Downloads 34 (535,888)

Abstract:

Loading...

3.

Immune Landscape of 382-Nt Deleted SARS-CoV-2 Reveals Heightened Adaptive Response Indicating Prophylactic Potential Against COVID-19

Number of pages: 90 Posted: 21 Oct 2020
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore General Hospital - Department of Infectious Diseases, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 18 (634,895)

Abstract:

Loading...

COVID-19, SARS-CoV-2, transcriptome, ORF8, deletion, RNA-seq

4.

Sensitive Detection of Total Anti-Spike Antibodies and Isotype Switching in Asymptomatic and Symptomatic COVID-19 Patients

Number of pages: 44 Posted: 23 Oct 2020
Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore General Hospital - Department of Infectious Diseases, Ng Teng Fong General Hospital - Division of Infectious Diseases, Changi General Hospital - Department of Infectious Diseases, Alexandra Hospital, National Centre for Infectious Diseases, National Centre for Infectious Diseases, Singapore, National Centre for Infectious Diseases, Singapore, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), National Centre for Infectious Diseases and Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre
Downloads 14 (663,548)

Abstract:

Loading...

SARS-CoV-2, COVID-19, serological, S protein, antibodies, IgG subclasses, symptomatic, asymptomatic

5.

Type I Interferon Shapes the Quantity and Quality of the Anti-Zika Virus Antibody Response

Number of pages: 45 Posted: 11 Apr 2019
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN)
Downloads 7 (716,714)

Abstract:

Loading...

Zika virus, type I interferon, humoral response, antibodies